Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • QE2
  • Latest news
  • Worldwide impact of NIBSC
  • Mission and values
  • Careers
  • Quality and governance
  • Staff profiles
  • Contact us
  • Collaborations
  • Suppliers
  • Scientific Advisory Committee
  • Minutes of the Animal Welfare and Ethical Review Body
  • Our use of animals
  • Privacy notice
  • Home  /  
  • About us  /  
  • Staff profiles  /  
  • Dr Andrew Macadam

Dr Andrew Macadam

Following completion of his PhD at Imperial College, London, Dr Andrew Macadam moved to NIBSC as a postdoc in 1987 working on the molecular basis of attenuation of poliovaccines. He joined the staff permanently in the 1990s and is currently a Principal Scientist in the Division of Virology where he runs a research group with interests in new approaches to polio vaccine design.

 
Current position

Principal Scientist, Division of Virology

Areas of interest

Poliovirus biology
Molecular basis of attenuation
New approaches to vaccine design

Qualifications

BA Biochemistry. Oxford University, 1982
PhD,  University of London, 1987

Recent publications (PDF, 84KB)
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap